483 Document: Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center, Apr 20, 2018

FDANews 483 Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center Apr 20 2018 top
Seneca D. Toms FDA Investigator Larry K. Hampton FDA Investigator

On Apr 20, 2018, the FDA inspected Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center's West Columbia site. Explore the inspectional observations.